Combined treatment with oxybutynin and imipramine in enuresis

Iranian Journal of Medical Sciences

Volumn 33, Issue 1, 2008, Pages 12-16

  Esmaeili, Mohamad ^a,c   Esmaeili, Marjan ^b  

^a Department of Pediatric Nephrology ^*  (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Enuresis; Imipramine; Oxybutynin

Indexed keywords

IMIPRAMINE; OXYBUTYNIN;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NOCTURNAL ENURESIS; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; TREATMENT OUTCOME;

EID: 41449102049     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Hjalmas K, Arnold T, Bower W, et al. Nocturnal enuresis: an international evidence based management strategy. J Urol 2004; 171: 2545-61.
2. Järvelin MR. Nocturanl enuresis. Acta Paediatr 1999; 88: 589-91.
3. Neveus T. Oxybutynin, desmopressin and enuresis. J Urol 2001; 166: 2459-62.
4. Husmann DA. Enuresis. Urology 1996; 48: 184-93.
5. Burke JR, Mizusawa Y, Chan A, et al. A comparison of amitriptyline, vasopressin and amitriptyline with vasopressin in nocturnal enuresis. Pediatr Nephrol 1995; 9: 438-40.
6. Lovering JS, Tallett SE, McKendry JB. Oxybutinin efficacy in the treatment of primary enuresis. Pediatrics 1988; 82:104-6.
7. Tahmaz L, Kibar Y, Yildirim I, et al. Combination therapy of imipramine with oxybutynin in children with enuresis nocturna. Urol Int 2000; 65: 135-9.
8. Kaneko K, Fujinaga S, Ohtomo Y, et al. Combined pharmacotherapy for nocturnal enuresis. Pediatr Nephrol 2001; 16: 662-4.
9. Läckgren G, Hjälmas K, van Gool J, et al. Nocturnal enuresis: a suggestion for a European treatment strategy. Acta Paediatr 1999; 88: 679-90.
10. Mark SD, Frank JD. Nocturnal Enuresis. Br J Urol 1995; 75: 427-34.
11. Yeung CK, Sit FK, To LK, et al. Reduction in nocturnal functional bladder capacity is a common factor in the pathogenesis of refractory nocturnal enuresis. BJU Int 2002; 90: 302-7.
12. Sullivan J, Abrams P. Pharmacological management of incontinence. Eur Urol 1999; 36: 89-95.
13. Smellie JM, McGrigor VS, Meadow SR, et al. Nocturnal enuresis: a placebo controlled trial of two antidepressant drugs. Arch Dis Child 1996; 75: 62-6.
14. Caione P, Arena F, Biraghi M, et al. octurnal enuresis and daytime wetting: a multicentric trial with oxybutynin and desmopressin. Eur Urol 1997; 31: 459-63.
15. Hjalmas K, Hellstrom AL, Mogren K, Lackgren G, Stenberg A. The overactive bladder in children: a potential future indication for tolterodine. BJU Int 2001; 87: 569-74.